The US market for vascular access devices is mature and will contract slightly over the forecast period. Rising unit sales, driven by an increasing patient pool in the US, will be offset by strong pricing pressures, which will result in declining ASPs in most product segments. Furthermore, recent physician-led guidelines will continue to drive a shift in vascular access device selection toward the use of less expensive midline catheters at the expense of PICCs, which will also contribute to declines in overall market revenue. Importantly, the impact of the COVID-19 pandemic on procedures, unit sales, and revenues has been incorporated into the market projections.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Vascular Access Devices in the US across a 10-year period.
Drastic shifts in device selection are occurring as a result of increased adherence of guidelines and rising prevalence of specialist vascular access teams.
How have usage practices shifted for PICCs, CVCs, and midline catheters?
What are some strategies that competitors have implemented to mitigate the effects of these changes?
What are the overall market implications arising from the rapid growth of the midline catheter market?
How are competitors engaging with the rising midline catheter market?
The lucrative US vascular access device market continues to experience strong pricing pressures.
What strategies can manufacturers implement to offset price pressures?
What innovations will facilitate device sales?
Which market segments are resisting these strong pricing pressures?
Nation-wide initiatives strongly limit the usage of dialysis catheters.
How will usage of dialysis catheters change in light of other recommended vascular access modalities?
How has the rise of indications requiring emergency dialysis impact the market for dialysis catheters?
The COVID-19 global pandemic will have a dual effect on the vascular access market in the short-term.
How will trends change in different vascular access device segments as a consequence of COVID-19?
What factors contribute to the market changes?
What plans are being executed by manufacturers in response to the pandemic?
- Vascular Access Devices - Market Insights - United States
Author(s): Jackie Liu
Jackie Liu is an analyst within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in peripheral vascular device markets. Jackie holds a PhD in Molecular Genetics and a MPH in Epidemiology from the University of Toronto. Prior to her current position, Jackie worked at multiple public health organizations in Ontario, gaining extensive experience with reporting and analyzing large-scale health data.